Farzana Sayani, MD MSc

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Penn Comprehensive Adult Thalassemia Program
Director, Penn Comprehensive Sickle Cell Program
Department: Medicine

Contact information
3rd Floor Dulles Building
3400 Spruce Street,
Philadelphia, PA 19104
Office: 215-615-6555
Fax: 215-615-6599
BSc (Cellular, Molecular and Microbial Biology)
University of Calgary, 1998.
MD (Medicine)
University of Calgary, 2001.
MSc (Haemoglobinopathies)
University College London, 2012.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

- Care of adult patients with sickle cell disease and thalassemia.
- Care of adult individuals with red cell disorders, including rare inherited red cell disorders.
- Transfusional iron overload.
- Transition of care for adult thalassemia and sickle cell patients from a pediatric to adult healthcare setting.

Description of Research Expertise

- Complications of in adults with thalassemia and sickle cell disease.
- iron overload in thalassemia.
- Improvement in care of patients with sickle cell disease and thalassemia.

Selected Publications

Jean-Fellix SA, Dolin C, Triebwasser J, Sayani F, Feldman R. : Contemporary obstetric and neonatal outcomes in sickle cell disease: a retrospective cohort study. American Journal of Obstetrics and Gynecology 226(13): S215-S216, January 2022.

Yui JC, Geara A, Sayani F. : Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload. Vox Sang 116 (7): 793-797, August 2021.

Roe AH, Lang B, McAllister A, Gaitors MC, Smith-Whitley K, Schreiber CA, Sayani F: Contraceptive use and preferences among females with sickle cell disease. Contraception Page: Epub online ahead of print, August 2021.

Farzana Sayani: Transitioning to adult healthcare in thalassemia: Q & A with Dr. Farzana Sayani. Cooleys Anemia Foundation Jan 2021 Notes: https://www.thalassemia.org/boduw/wp-content/uploads/2021/01/QA-with-Dr.-Sayani-Transitioning-to-Adult-Healthcare-in-Thalassemia.pdf.

Arnold T, By S, Dyvorne H, O'Halloran R, Sayani F, Desiderio L, Litt B, Stein J. : In-vivo ferumoxytol imaging and T1/T2 characterization at 64mT. International Society for Magnetic Resonance in Medicine (ISMRM) 2021.

Nabavizadeh, A, Chawla S, Wu P, Rodriguez A, Englund E, Langham M, Sayani F, Russell E, Wehrli F.: Whole-Brain Brain Oxygen Metabolism in Adult Sickle-Cell Patients Using Two Different Quantitative MRI Approaches. American Society of Neuroradiology, 58th Annual Meeting. May 2020.

OncLive - Peer Exchange: Management of Beta Thalassemia. \{OncLive - Peer Exchange} 2020 Notes: Panel Interview https://www.onclive.com/view/managementofbetathal.

Farzana Sayani MD: What is Beta-Thalassemia Major. CheckRare.com. checkrare.com, 2020 Notes: CheckRare is a leading publisher and learning platform focused on rare diseases.

Cappellini MD, Viprakasit V, Taher AT et al. : A phase 3 trial of Luspatercept in patients with transfusion depdenta beta thalassemia. New England Journal of Medicine 382(13): 1219-1231, 2020.

Farzana Sayani MD: Sickle Cell Disease Explained. CheckRare.com. CheckRare.com, 2020 Notes: CheckRare is a leading published and learning platform focused on rare diseases.

back to top
Last updated: 01/30/2022
The Trustees of the University of Pennsylvania